Prevalence of “Ghost Infarct Core” after Endovascular Thrombectomy

REFERENCES

1. 1.↵
   1. Goyal M,
   2. Menon BK,
   3. van Zwam WH

   , HERMES Collaborators, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 2016;387:1723–31 doi:10.1016/S0140-6736(16)00163-X pmid:26898852

   CrossRefPubMed
2. 2.↵
   1. Powers WJ,
   2. Rabinstein AA,
   3. Ackerson T

   , American Heart Association Stroke Council, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018;49:e46–10 doi:10.1161/STR.0000000000000158 pmid:29367334

   Abstract/FREE Full Text
3. 3.↵
   1. Albers GW,
   2. Marks MP,
   3. Kemp S

   , DEFUSE 3 Investigators, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med 2018;378:708–18 doi:10.1056/NEJMoa1713973 pmid:29364767

   CrossRefPubMed
4. 4.↵
   1. Nogueira RG,
   2. Jadhav AP,
   3. Haussen DC

   , DAWN Trial Investigators, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med 2018;378:11–21 doi:10.1056/NEJMoa1706442 pmid:29129157

   CrossRefPubMed
5. 5.↵
   1. Turc G,
   2. Bhogal P,
   3. Fischer U, et al

   . European Stroke Organisation (ESO): European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischemic Stroke. J Neurointerv Surg 2019;11:535–38 doi:10.1136/neurintsurg-2018-014569 pmid:30808653

   Abstract/FREE Full Text
6. 6.↵
   1. Powers WJ,
   2. Rabinstein AA,
   3. Ackerson T, et al

   . Guidelines for the early management of patients with acute ischemic stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019;50:e344–e418 doi:10.1161/STR.0000000000000211 pmid:31662037

   CrossRefPubMed
7. 7.↵
   1. Campbell BC,
   2. Mitchell PJ,
   3. Kleinig TJ

   , EXTEND-IA Investigators, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med 2015;372:1009–18 doi:10.1056/NEJMoa1414792 pmid:25671797

   CrossRefPubMed
8. 8.↵
   1. Boned S,
   2. Padroni M,
   3. Rubiera M, et al

   . Admission CT perfusion may overestimate initial infarct core: the ghost infarct core concept. J Neurointerv Surg 2017;9:66–69 doi:10.1136/neurintsurg-2016-012494 pmid:27566491

   Abstract/FREE Full Text
9. 9.↵
   1. Martins N,
   2. Aires A,
   3. Mendez B, et al

   . Ghost infarct core and admission computed tomography perfusion: redefining the role of neuroimaging in acute ischemic stroke. Interv Neurol 2018;7:513–21 doi:10.1159/000490117 pmid:30410531

   CrossRefPubMed
10. 10.↵
    1. Hill MD,
    2. Goyal M,
    3. Menon BK

    , ESCAPE-NA1 Investigators, et al. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet 2020;395:878–87 doi:10.1016/S0140-6736(20)30258-0 pmid:32087818

    CrossRefPubMed
11. 11.↵
    1. Huo X,
    2. Ma G,
    3. Tong X, et al

    . Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med 2023;388:1272–83 doi:10.1056/NEJMoa2213379 pmid:36762852

    CrossRefPubMed
12. 12.↵
    1. Sarraj A,
    2. Hassan AE,
    3. Abraham MG

    , SELECT2 Investigators, et al. Trial of endovascular thrombectomy for large ischemic strokes. N Engl J Med 2023;388:1259–71 doi:10.1056/NEJMoa2214403 pmid:36762865

    CrossRefPubMed
13. 13.↵
    1. Yoshimura S,
    2. Sakai N,
    3. Yamagami H, et al

    . Endovascular therapy for acute stroke with a large ischemic region. N Engl J Med 2022;386:1303–13 doi:10.1056/NEJMoa2118191 pmid:35138767

    CrossRefPubMed
14. 14.↵
    1. Ospel JM,
    2. Singh R,
    3. Kashani N, et al

    . Endovascular treatment decision making in patients with low baseline ASPECTS: insights from UNMASK EVT, an international multidisciplinary study. J Stroke Cerebrovasc Dis 2020;29:105411 doi:10.1016/j.jstrokecerebrovasdis.2020.105411 pmid:33254375

    CrossRefPubMed
15. 15.↵
    1. Jones TH,
    2. Morawetz RB,
    3. Crowell RM, et al

    . Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981;54:773–82 doi:10.3171/jns.1981.54.6.0773 pmid:7241187

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Rotem SH,
    2. Mor S,
    3. Chen B, et al

    . Infarct core reliability by CT perfusion is a time-dependent phenomenon. J Neuroimaging 2020;30:240–45 doi:10.1111/jon.12692 pmid:32037630

    CrossRefPubMed
17. 17.↵
    1. Nagakane Y,
    2. Yamada K,
    3. Ohara T, et al

    . Preferred involvement of the basal ganglia after lenticulostriate infarction as a possible indicator of different gray and white matter vulnerability. Stroke 2008;39:494–96 doi:10.1161/STROKEAHA.107.484337 pmid:18174493

    Abstract/FREE Full Text
18. 18.↵
    1. Ay H,
    2. Koroshetz WJ,
    3. Vangel M, et al

    . Conversion of ischemic brain tissue into infarction increases with age. Stroke 2005;36:2632–36 doi:10.1161/01.STR.0000189991.23918.01 pmid:16269639

    Abstract/FREE Full Text
19. 19.↵
    Changes in neurovascular function in brain microvessels during aging. Nature Aging 2023;3:153–54 doi:10.1038/s43587-022-00355-0 pmid:7118119

    CrossRefPubMed
20. 20.↵
    1. Ballout AA,
    2. Oh SY,
    3. Huang B, et al

    . Ghost infarct core: a systematic review of the frequency, magnitude, and variables of CT perfusion overestimation. J Neuroimaging 2023;33:716–24 doi:10.1111/jon.13127 pmid:37248074

    CrossRefPubMed
21. 21.↵
    1. Konduri P,
    2. Bucker A,
    3. Boers A

    , MR CLEAN Trial Investigators (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands), et al. Risk factors of late lesion growth after acute ischemic stroke treatment. Front Neurol 2022;13:977608 doi:10.3389/fneur.2022.977608 pmid:36277932

    CrossRefPubMed